This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogène
This ACVR2A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 2-29 amino acids from the N-terminal region of human ACVR2A.
anticorps ACVR2, anticorps ACVR2A, anticorps XSTK9, anticorps actrii, anticorps acvr2, anticorps ACTRII, anticorps Acvr2, anticorps rActR-II, anticorps actr2a, anticorps acvr2a, anticorps wu:fa02e10, anticorps ActrIIa, anticorps TactrII, anticorps activin A receptor type 2A, anticorps activin A receptor type 2A L homeolog, anticorps activin A receptor type 2Aa, anticorps activin receptor IIA, anticorps ACVR2A, anticorps acvr2a, anticorps Acvr2a, anticorps acvr2a.L, anticorps acvr2aa
Sujet
ACVR2A is an activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling, and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases.